| GC30959-10mM(1mLinDMSO) |
|
94-15-5 |
|
0 |
C16H26N2O2 |
|
|
|
| GC30957-50mg |
|
550-83-4 |
Propoxycaine hydrochloride
|
0 |
C16H27ClN2O3 |
|
|
|
| GC30957-10mM(1mLinDMSO) |
|
550-83-4 |
Propoxycaine hydrochloride
|
0 |
C16H27ClN2O3 |
|
|
|
| GC30956-100mg |
|
36304-84-4 |
|
0 |
C18H28NO4P |
|
|
|
| GC30956-50mg |
|
36304-84-4 |
|
0 |
C18H28NO4P |
|
|
|
| GC30956-10mM(1mLinDMSO) |
|
36304-84-4 |
|
0 |
C18H28NO4P |
|
|
|
| GC30955-20mg |
|
51598-60-8 |
Cimetropium Bromide (DA-3177)
|
0 |
C21H28BrNO4 |
|
|
|
| GC30955-10mg |
|
51598-60-8 |
Cimetropium Bromide (DA-3177)
|
0 |
C21H28BrNO4 |
|
|
|
| GC30955-5mg |
|
51598-60-8 |
Cimetropium Bromide (DA-3177)
|
0 |
C21H28BrNO4 |
|
|
|
| GC30955-1mg |
|
51598-60-8 |
Cimetropium Bromide (DA-3177)
|
0 |
C21H28BrNO4 |
|
|
|
| GC30955-10mM(1mLinDMSO) |
|
51598-60-8 |
Cimetropium Bromide (DA-3177)
|
0 |
C21H28BrNO4 |
|
|
|
| GC30954-100mg |
|
749269-83-8 |
|
0 |
C16H11Cl2FO2 |
|
|
|
| GC30954-50mg |
|
749269-83-8 |
|
0 |
C16H11Cl2FO2 |
|
|
|
| GC30954-10mg |
|
749269-83-8 |
|
0 |
C16H11Cl2FO2 |
|
|
|
| GC30954-5mg |
|
749269-83-8 |
|
0 |
C16H11Cl2FO2 |
|
|
|
| GC30954-10mM(1mLinDMSO) |
|
749269-83-8 |
|
0 |
C16H11Cl2FO2 |
|
|
|
| GC30953-100mg |
|
102-02-3 |
Phenylbiguanide (N-Phenylbiguanide)
|
0 |
C8H11N5 |
|
|
|
| GC30953-10mM(1mLinDMSO) |
|
102-02-3 |
Phenylbiguanide (N-Phenylbiguanide)
|
0 |
C8H11N5 |
|
|
|
| GC30952-50mg |
|
566169-98-0 |
4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine
|
0 |
C14H11BrN2S |
|
|
|
| GC30952-10mg |
|
566169-98-0 |
4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine
|
0 |
C14H11BrN2S |
|
|
|
